Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
22.48
-0.78 (-3.35%)
At close: Apr 24, 2026, 4:00 PM EDT
22.47
-0.01 (-0.03%)
After-hours: Apr 24, 2026, 7:59 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $2.24 billion as of April 24, 2026. Its market cap has increased by 423.54% in one year.
Market Cap
2.24B
Enterprise Value
1.87B
1-Year Change
423.54%
Ranking
Category
Stock Price
$22.48
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $2.24B, an increase of 276.44%. That is a compound annual growth rate of 24.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 2.24B | 69.91% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ultragenyx Pharmaceutical | 2.36B |
| Mineralys Therapeutics | 2.27B |
| Tyra Biosciences | 2.24B |
| Day One Biopharmaceuticals | 2.22B |
| Ascentage Pharma Group International | 2.20B |
| Adaptive Biotechnologies | 2.18B |
| Sarepta Therapeutics | 2.13B |
| Aurinia Pharmaceuticals | 2.12B |